Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Healthcare Services. Per the activity note to the FY2024 annual report, the company operates as a clinical research organization conducting trials and studies globally.
Subsidiary of Shezghuduli Pasukhismgeblobis Sazogadoeba Pareksel International Holding Bi.vi. (100.0%)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|
| 1,734 | 2,126 | 3,140 | 9,086 | 3,751 | 4,549 | +21.3% | |
| 363 | 239 | 293 | 313 | 352 | 404 | +2.1% | |
| TOTAL ASSETS | 2,097 | 2,366 | 3,433 | 9,399 | 4,103 | 4,953 | +18.7% |
| 315 | 367 | 1,141 | 7,091 | 1,096 | 1,305 | +32.9% | |
| 30 | 31 | 31 | 0 | 0 | 0 | +1.5% | |
| TOTAL LIABILITIES | 345 | 398 | 1,172 | 7,091 | 1,096 | 1,305 | +30.5% |
| 1,752 | 1,968 | 2,261 | 2,308 | 3,007 | 3,647 | +15.8% | |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | |||||||
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cash & Equivalents | 1,239 | 1,063 | 2,935 | 1,865 | 2,537 | 2,446 | +14.6% |
| Net Debt | 1,239 | 1,063 | 2,935 | 1,865 | 2,537 | 2,446 | +14.6% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →